AQST Earnings — Aquestive Therapeutics, Inc. Common Stock Post-ER Performance | BigEarnings
AQST — Aquestive Therapeutics, Inc. Common Stock
XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Price$4.02
Market Cap$501.8M
P/E—
52W Range$2.50 – $7.55
Next Earnings2026-08-10
About Aquestive Therapeutics, Inc. Common Stock
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
